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Abstract
A distinct pathovar of Salmonella enterica serovar Typhimurium, ST313, has emerged in
sub-Saharan Africa as a major cause of fatal bacteremia in young children and HIV-infected
adults. D23580, a multidrug resistant clinical isolate of ST313, was previously shown to
have undergone genome reduction in a manner that resembles that of the more human-
restricted pathogen, Salmonella enterica serovar Typhi. It has since been shown through
tissue distribution studies that D23580 is able to establish an invasive infection in chickens.
However, it remains unclear whether ST313 can cause lethal disease in a non-human host
following a natural course of infection. Herein we report that D23580 causes lethal and inva-
sive disease in a murine model of infection following peroral challenge. The LD50 of D23580
in female BALB/c mice was 4.7 x 105 CFU. Tissue distribution studies performed 3 and 5
days post-infection confirmed that D23580 was able to more rapidly colonize the spleen,
mesenteric lymph nodes and gall bladder in mice when compared to the well-characterized
S. Typhimurium strain SL1344. D23580 exhibited enhanced resistance to acid stress rela-
tive to SL1344, which may lend towards increased capability to survive passage through
the gastrointestinal tract as well as during its intracellular lifecycle. Interestingly, D23580
also displayed higher swimming motility relative to SL1344, S. Typhi strain Ty2, and the
ST313 strain A130. Biochemical tests revealed that D23580 shares many similar metabolic
features with SL1344, with several notable differences in the Voges-Proskauer and cata-
lase tests, as well alterations in melibiose, and inositol utilization. These results represent
the first full duration infection study using an ST313 strain following the entire natural course
of disease progression, and serve as a benchmark for ongoing and future studies into the
pathogenesis of D23580.
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Author Summary
A deadly form of non-typhoidal Salmonella has emerged as a major cause of invasive dis-
ease in sub-Saharan Africa. Initial genomic profiling of this novel Salmonella sequence
type, ST313, indicated that although it is technically classified as S. Typhimurium (a sero-
var characterized by a broad host range), it may be evolving towards becoming a more
human-specific, ‘typhoid-like’ pathogen. However, it was recently demonstrated that
ST313 strains were indeed able to establish an invasive and damaging infection in chick-
ens. Despite these important findings, it remains unclear whether ST313 is able to cause
lethal disease in a non-human host, since no study has yet followed the entire natural
course of disease progression. As such, there are no data available concerning the median
lethal dose (LD50) of any ST313 strain. This is an important metric, as the LD50 value will
serve as a benchmark for mechanistic studies focused on understanding the relationship
between virulence and the phenotypic and molecular genetic attributes associated with
ST313 infections. Here we report that D23580 causes lethal disease in BALB/c mice and
determined the LD50 following peroral challenge. Phenotypic characterization revealed
distinct differences in tissue distribution, acid stress resistance, and biochemical utilization
between D23580 and the ‘classic’ Typhimurium strain SL1344.
Introduction
Infectious diseases caused by multidrug resistant (MDR) pathogens continue to be a major
global health crisis and challenge current treatment regimens. Invasive non-typhoidal salmo-
nellae (iNTS) are a leading cause of bloodstream infections in sub-Saharan Africa, and are of
serious concern due to high rates of morbidity and mortality coupled with increasing problems
of MDR [1–4]. iNTS have replaced pneumococcus as the most frequent cause of bacteremia in
several countries, with Salmonella enterica serovar Typhimurium (S. Typhimurium) identified
as one of the most common serovars recovered from patients with iNTS infections [1–7].
There is currently no vaccine available for prevention of iNTS disease in humans.
Kingsley et al. first reported in 2009 that a phylogenetically distinct pathovar of S. Typhi-
murium belonging to a novel multilocus sequence type (MLST) designated as ST313 had
emerged as a significant cause of morbidity and mortality among HIV-positive adults and chil-
dren suffering from malaria, severe anemia and/or malnutrition [1]. Case fatality rates are
high, ranging from 20–25% in children and extend up to ~50% in HIV-infected adults [1].
Recurrence of the disease due to recrudescence of the same strain and/or reinfection with a sep-
arate iNTS strain occurs frequently, and can lead to high mortality rates over the long term [8].
No animal reservoir has been identified thus far for ST313, and it has been suggested that
unlike other ‘classical’ foodborne NTS infections, which are often transmitted via zoonotic
routes, ST313 strains may pass primarily through human-to-human contact, [5,6]. Rapid and
accurate diagnosis is often hindered by the non-specific clinical symptoms associated with the
disease, which most commonly present only as a fever with a subset of patients experiencing
splenomegaly [1,3,9]. There is also a marked lack of gastroenteritis in most cases that is often
characteristic of NTS infections (<50% of cases) [1,3]. Moreover, the increasing problem of
MDR to commonly used antibiotics including ampicillin, trimethoprim-sulfamethoxazole, and
chloramphenicol, presents additional challenges in these impoverished regions, as cost and
availability can preclude the use of alternative antimicrobial agents [2,8]. Due to the lack of
blood diagnostic facilities in many regions where ST313 infections are the most rampant, treat-
ment using an inadequate antibiotic regimen following a misdiagnosis often fails to combat the
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infection [3]. However, even with the appropriate diagnosis and implementation of a rigorous
antibiotic regimen, the average case fatality rates still hover around 25% [2].
There is urgent need to understand the pathogenic strategies used by these deadly iNTS
strains to cause disease in order to facilitate the development of novel diagnostic tools and for
the design of effective treatments and prevention strategies. In recent years, attention has been
given towards understanding the distinctive cellular and humoral immune responses associ-
ated with ST313 infections [3,10–17] as well as the unique genotypic and phenotypic character-
istics associated with the ST313 pathovar [1,5,6,14,18–25]. Kingsley et al. performed MLST
profiling of 51 iNTS isolates recovered fromMalawi and Kenya during the peak of the Blantyr
epidemic and identified ST313 as the dominant genotype responsible for iNTS disease in the
region [1]. Whole genome sequencing of D23580, a representative MDR ST313 clinical isolate
from a pediatric patient in Malawi, indicated that the strain had undergone genome reduction
similar to that of other human-restricted serovars like Salmonella enterica serovar Typhi (S.
Typhi) [1]. D23580 was found to contain a novel prophage repertoire, as well as the presence
of a large insertion of MDR genes on the large pSLT-BT plasmid. Importantly, a large number
of the pseudogenes and deletions identified are consistent with what has been observed for S.
Typhi [1]. These findings, together with the previous clinical and epidemiological observations,
including a routine lack of gastroenteritis and evidence of human-to-human transmission, sug-
gested the possibility that the ST313 pathovar may be evolving towards a more host-restricted
phenotype similar to that of S. Typhi [1,18].
Recent studies have confirmed that despite some similarities to S. Typhi, D23580 still retains
a broad host tropism characteristic of S. Typhimurium ([14,18], this work). Tissue distribution
studies conducted in chickens by Parsons et al. were the first to demonstrate that D23580 is
able to infect chickens and displays an invasive phenotype [18]. D23580 colonized the ceca,
spleen and liver, and elicited a rapid inflammatory CXC chemokine response in the intestine
[18]. Comparisons made to ST19 isolates 4/74 and F98 indicated that D23580 invaded deeper
into the spleen and liver, and colonized the intestinal tract at lower levels. Subsequent studies
conducted by Herrero-Fresno et al. in C57/BL6 mice sought to understand the role of the
uncharacterized gene, st313-td, in ST313 pathogenesis [14,20]. Competition experiments
between the wild type ST313 strain 02-03/002 and the st313-td deletion mutant following intra-
peritoneal (i.p.) challenge indicated that while both the wild type and the mutant were able to
colonize the spleen, deletion of st313-td led to a severe decrease in invasiveness. These findings
correlated well with human clinical data, wherein the presence of the st313-td gene in S. Typhi-
murium correlated strongly with invasiveness with respect to systemic infection [14]. More-
over, it was found that while the presence of the gene did not impact invasion into Int-407
intestinal epithelial monolayer cultures, it did affect survival in J774 macrophages [14]. Along
these lines, it was recently found that ST313 strains were phagocytosed more efficiently and
were highly resistant to killing by macrophages of both human and mouse origin, relative to
ST19 isolates [26].
While the previous studies have demonstrated that ST313 strains are capable of causing a
systemic infection in both chickens and mice, to our knowledge no study to date has yet
assessed the lethality of ST313 in animals. Herein we the report the median lethal dose (LD50)
of the ST313 strain D23580 in 8-week-old female BALB/c mice following peroral (p.o.) infec-
tion. Comparisons made between the tissue colonization patterns of D23580 and the classic S.
Typhimurium strain SL1344 revealed distinct differences between the two strains and indicated
that D23580 was able to more rapidly colonize the spleen, mesenteric lymph nodes and gall
bladder in mice. In addition, several assays including acid stress, motility and biochemical pro-
filing were conducted in order to better understand how these factors could play a role in the
pathogenesis of D23580.
In Vivo and In Vitro Characterization of D23580
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Methods
Ethics statement
This study was reviewed and approved by the Arizona State University Institutional Animal
Care and Use Committee (IACUC) under protocol number 14-1343-R. All animals were
housed in accordance with the American Association for Laboratory Animal Care (AALAC)
standards, provided unlimited access to food and water, and handled in accordance with the
Animal Welfare Act and Institutional Animal Care and Use Committee (IACUC) regulations.
Experiments involving animals were conducted in a facility fully accredited by the Association
for Assessment and Accreditation of Laboratory Animal Care International (Unit #000765)
and an assurance is on file with the Office for Laboratory Animal Welfare (#A3217-01). Experi-
ments were planned and conducted utilizing the three R's (reduce, replace and refine), which
included environmental enrichment, veterinary oversight, numbers reflecting statistical signifi-
cance and the use of appropriate analgesics and anesthesia when appropriate. Mice used in this
study were euthanized by CO2 asphyxiation, which is consistent with the most recent recom-
mendations of the American Veterinary Medical Association (AVMA) Panel on Euthanasia.
Cervical dislocation or secondary thoracotomy was used as a subsequent secondary measure.
Bacterial strains and growth conditions
Bacterial strains used in this study are listed in Table 1 [1,27–29]. For all animal studies and
stress assays, bacterial cultures were initiated in Lennox broth (LB) with aeration (180 rpm)
overnight for 15 hours at 37°C. The following day, overnight cultures were inoculated into 50
mL sterile LB at a 1:200 dilution and subsequently grown to late log/early stationary phase at
37°C with aeration. To confirm that all bacterial strains used in animal studies and stress assays
were at the same phase of growth for all studies, growth curves were performed for those
strains under these conditions by plating on LB agar for viable colony-forming units (CFU)
and measuring the corresponding optical density at 600 nm (OD600) (S1 Fig).
Virulence studies
The virulence of D23580 in 8-week old female BALB/c mice (Charles River Laboratories) was
determined by p.o. administration using standard protocols described previously [30]. D23580
was cultured to late log/early stationary phase as described above and harvested by centrifuga-
tion at 7,000 rpm for 10 minutes. Pellets were resuspended in 1 mL of buffered saline contain-
ing 0.01% gelatin (BSG) to a dose of approximately 1x109 CFU per 20 μl. A series of 10-fold
dilutions was performed in BSG down to 1x102 CFU per 20 μl dose. Animal inoculations for
the determination of the 50% lethal dose (LD50) values were performed as described previously
Table 1. Bacterial strains.
Genus and subspecies Strain Characteristics References
S. Typhimurium SL1344 Wild-type, (SmR) (27)
S. Typhimurium D23580 ST313, clinical isolate, (SmSuChAWR, KmS) (1)
S. Typhimurium A130 ST313, clinical isolate, (SuKmAWR, SmChS) (1)
S. Typhi Ty2 Wild-type, RpoS-,Cys-,OD1:Hd:-:Vi, V form (29)
Sm, streptomycin; Su, sulphonamide; Ch, chloramphenicol; Km, kanamycin; A, ampicillin; W, trimethoprim
R, resistant
S, sensitive.
doi:10.1371/journal.pntd.0003839.t001
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[30]. Studies were performed in biological triplicate with five mice per dose. The LD50 value
was calculated using two of these independent trials, since in the initial trial the dosage was not
yet optimized and there was no group with 100% survival, which is a requirement to calculate
the median lethal dose using the method of Reed and Muench [31]. Time-to-death (Fig 1) was
plotted to include the results from all three trials. Mice were monitored for up to 30 days for
both the LD50 and time-to-death studies.
Tissue distribution studies
Dissemination of D23580 and SL1344 in mice was assessed by separate p.o. inoculations into
8-week old female BALB/c mice. Bacteria were cultured and harvested as described above.
Approximately 5x108 CFU per 20 μl was used for inoculating each mouse. Three groups of five
mice were infected with D23580, and a matching number of groups with SL1344. Quantitation
of viable bacteria in tissues and organs at days 1, 3 and 5 post-infection was performed as
described previously [30]. Briefly, mice were euthanized with CO2, and tissues of interest were
promptly dissected and weighed. Bacteria were enumerated from the following tissues/regions:
Peyer’s patches (7–11 per mouse), intestinal contents, intestinal wall (small and large intestines
with Peyer’s patches removed), mesenteric lymph nodes (3–5 per mouse), spleen, and gall blad-
der. Phosphate buffered saline (PBS) was added to a total volume of 1 mL for each isolated tis-
sue, except for intestinal contents and intestinal wall which required resuspension in a total
volume of 5 mL PBS. Samples were homogenized with a TissueRuptor (Qiagen) on ice, serially
diluted and plated on MacConkey agar plates containing 1% lactose and 20 μg/ml streptomycin
in triplicate (both SL1344 and D23580 are resistant to streptomycin). Plates were incubated
overnight at 37°C and the number of colonies enumerated the following day. The data repre-
sent an average of two independent trials and are presented as mean of either the CFU per
gram of tissue or per total organ (for mesenteric lymph nodes and gall bladder). Statistical
comparisons were made using the Mann-Whitney test (p< 0.05).
Fig 1. Survival of mice following peroral infection with D23580. D23580 was cultured to late log phase and administered p.o. to 8-week-old female BALB/
c mice at inoculum titers ranging from 102–109 CFU per dose. The data shown represent the combined results from three independent trials. The median
lethal dose was determined by the method of Reed and Muench [31] using two of these independent trials (see Methods section). The percent survival is
defined as the percentage of mice surviving at the indicated number of days post-infection.
doi:10.1371/journal.pntd.0003839.g001
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Motility assays
Bacterial strains were each profiled for swimming motility on plates containing 0.3% top agar
and 1.5% bottom agar containing 0.5% NaCl, 1% tryptone and 0.3% glucose. Overnight cul-
tures of each strain were diluted 1:1000 and then spotted onto the agar using a sterile pipette
tip. Plates were incubated at 37°C overnight for 8 hours. Experiments were performed in bio-
logical duplicate and technical triplicate.
Acid stress survival assays
Bacteria were grown as described above to late log/early stationary phase, and immediately
subjected to acidic conditions through the addition of a citrate buffer to lower the pH to 3.5.
Cells were incubated statically at room temperature during exposure to the stress and the pH
was confirmed with an electrode at the end of the assay. Samples were removed at time zero
(before the addition of stress) and at various time points thereafter, diluted in phosphate buff-
ered saline (PBS) and then plated on LB agar to determine the numbers of viable CFU. Percent
survival was calculated as the number of CFU at each time point divided by the number of
CFU at time zero. At least three independent trials were performed. Statistical comparisons
were made using the Student’s t-test (p< 0.05).
Biochemical analysis
Biochemical analysis of bacterial cultures was performed using the API 20E kit (bioMérieux,
Durham, NC), according to the manufacturer’s instructions. The citrate test results were con-
firmed by using Simmons citrate media. A needle containing pure bacterial culture was tabbed
twice into Simmons citrate agar slant media, and then streaked from the base of the tube up
along the surface of the slant. For the catalase test, bacterial colonies of each strain were picked
from plates grown overnight at 37°C on sterile polystyrene plastic petri dishes (USA Scientific).
One to two drops of hydrogen peroxide was then added simultaneously to each strain and
immediately imaged for bubble formation as evidence of catalase activity.
Results
Virulence of D23580
To assess the lethality of D23580 in mice, we performed p.o. inoculations of eight-week-old
female BALB/c mice with a series of doses ranging from 109 to 102 CFU per dose, with five
mice per dose. Results shown in Fig 1 correspond to representative data from three indepen-
dent virulence assays. The LD50 following p.o. infection was 4.75 x 10
5 CFU. This LD50 is over
4 times lower than what has been previously reported for SL1344 in BALB/c mice using bacte-
ria cultured to the same phase of growth and an oral route of infection (2 x 105–5 x 105 CFU)
[32,33].
D23580 is recovered from the spleen and gall bladder of BALB/c mice at
higher numbers than SL1344
To assess the pattern of systemic spread of D23580 in mice following p.o. infection relative to
the well-characterized S. Typhimurium strain SL1344, we infected groups of eight-week-old
female BALB/c mice with either D23580 or SL1344 at 5 x 108 CFU per dose and determined
the CFU of the two strains in several different tissues. Quantitation of viable bacteria in tissues
and organs at days 1, 3 and 5 post-infection was performed for the following: intestinal con-
tents, Peyer’s patches, intestinal wall (small and large intestine excluding Peyer’s patches),
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mesenteric lymph nodes, spleen, and gall bladder. Fig 2 shows the results from 3 and 5 days
post-infection, as no differences were observed one day post-infection (S2 Fig). At Day 3, no
statistical differences were observed in the colonization of the Peyer’s patches of D23580 com-
pared to SL1344 (Fig 2A; p = 0.2396), although a slight upward trend could be observed for
D23580. Similarly, in the mesenteric lymph nodes an increased trend could be observed for
D23580, but the differences were not statistically significant (Fig 2B; 81.3-fold, p = 0.1056).
However, D23580 exhibited an enhanced ability to colonize the spleen relative to SL1344 (Fig
2C; 56.8-fold, p<0.05). No significant differences were observed for the intestinal contents or
intestinal wall (excluding Peyer’s patches, S2 Fig), or for the gall bladder on day 3 (Fig 2D).
Fig 2. Tissue distribution of D23580 and SL1344 in mice following peroral infection. D23580 or SL1344 cultured to late log phase was administered
perorally to 8-week-old female BALB/c mice at 108 CFU per dose. Peyer’s patches (A), mesenteric lymph nodes (B), spleen (C) and gall bladder (D) were
excised at 3 and 5 days after peroral infection. Five mice were euthanized at each time point per strain per experiment. The data represent an average of two
trials and are presented as the mean of either the CFU per gram of tissue or per total organ (for mesenteric lymph nodes and gall bladder). The horizontal bar
indicates geometric means and statistical comparisons were made using the Mann-Whitney test (** indicates p < 0.01; * indicates p < 0.05).
doi:10.1371/journal.pntd.0003839.g002
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By Day 5, D23580 was still present at significantly higher levels in the spleen (Fig 2C;
54.9-fold, p< 0.01) and had spread to the gall bladder at higher counts relative to SL1344
(Fig 2D; 14.4-fold, p< 0.05), which is a hallmark of Typhi infections. The enhanced ability for
D23580 to reach the deeper tissues like the spleen and gall bladder as compared to a strain
belonging to the ST19 pathovar (SL1344) is consistent with previous findings by Parsons et al.
that found the ST19 isolates 4/74 and F98 were slower to invade into the spleen and liver of
chickens than D23580 [18].
Acid stress resistance
We considered that D23580 might be recovered in higher numbers from the gallbladder, spleen
and MLNs as compared to SL1344 due to increased resistance to environmental stresses nor-
mally encountered in these tissues. Thus, to identify potential phenotypic traits of D23580 that
may confer a selective advantage for its enhanced dissemination into these tissues as compared
to SL1344, we profiled the ability of these two strains to resist low pH, a physiologically relevant
stressor normally encountered by Salmonella both during transit through the stomach and
during intracellular lifestyle within the host [34–36]. As shown in Fig 3, D23580 displayed
enhanced resistance to pH 3.5 than SL1344 for all time points tested (p< 0.05).
Motility
The swimming motility of D23580 was profiled and compared to SL1344. For a broader
comparison, we also included ST313 strain A130 and typhoidal strain Ty2. A130 is a chloram-
phenicol sensitive ST313 isolate recovered in 1997, prior to the emergence of the full MDR phe-
notype found in D23580 [1]. As shown in Fig 4, D23580 exhibited the highest swimming
Fig 3. Survival of D23580 and SL1344 at pH 3.5. D23580 (black bars) and SL1344 (white bars) were
cultured to late log phase, and immediately subjected to acidic conditions through the addition of a citrate
buffer to lower the pH to 3.5. Samples were removed at time zero (before the addition of stress) and at
various time points thereafter, diluted in phosphate buffered saline (PBS) and then plated on LB agar to
determine the numbers of viable CFU. Percent survival was calculated as the number of CFU at each time
point divided by the number of CFU at time zero. At least three independent trials were performed. Statistical
comparisons were made using the Student’s t-test (** indicates p < 0.01; * indicates p < 0.05).
doi:10.1371/journal.pntd.0003839.g003
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motility of all strains profiled. This heightened motility was not conserved across all ST313 iso-
lates, as A130 appeared to be much less motile.
Biochemical profiling
The flexible metabolic capabilities that are characteristic of enteric pathogens like Salmonella
may confer a selective advantage during colonization of host tissues [37]. During their natural
life cycle, salmonellae adapt to a wide variety of environmental niches both inside and outside
of the host that vary in nutrient availability. Understanding the biochemical features that dis-
tinguish D23580 from other NTS strains may provide insight into selective pressures influenc-
ing its ability to colonize and spread within the infected host. Table 2 shows the results of the
biochemical assessment. The data obtained for D23580 and SL1344 showed identical results
for the ornithine decarboxylase, hydrogen sulfide production, and rhamnose and arabinose fer-
mentation/ oxidation tests.
There were striking differences that distinguished D23580 and A130 from other Salmonella
strains tested. One difference was the ability of both ST313 strains to ferment inositol, while
SL1344 and Ty2 were unable to use this carbohydrate as a sole carbon source. Inositol is pro-
duced naturally in the human body, and is found at high levels in the human brain [38], and is
also found in certain foods like beans, rice and cereals as well as in soil. While certain Salmo-
nella strains have the capability to utilize inositol as a carbon source, it is not ubiquitous [39].
Along these same lines, we also found that D23580 was unable to ferment melibiose, a sugar
most commonly found in plants, especially legumes. In contrast, all other Salmonella strains,
including A130, were still melibiose positive. Interestingly, although approximately 95% of Sal-
monella species are melibiose fermenters, it has been previously reported that a loss in the
Fig 4. Swimmingmotility of ST313 strains relative to classic NTS and typhoidal strains. Salmonella
strains D23580, SL1344, A130, and Ty2 (identified as D, SL, A, and T respectively in the figure) were each
profiled for swimming motility on agar plates containing 0.3% agar, 0.5% NaCl, 1% tryptone. Overnight
cultures of each strain were diluted 1:1000 and then spotted onto the agar using a sterile pipette tip. Plates
were incubated at 37°C overnight for 8 hours. Experiments were performed in biological duplicate and
technical triplicate.
doi:10.1371/journal.pntd.0003839.g004
In Vivo and In Vitro Characterization of D23580
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0003839 June 19, 2015 9 / 17
T
ab
le
2.
B
io
ch
em
ic
al
ch
ar
ac
te
ri
za
ti
o
n
o
fS
T
31
3
st
ra
in
s.
A
m
in
o
A
ci
d
D
ec
ar
b
o
xy
la
ti
o
n
C
ar
b
o
h
yd
ra
te
fe
rm
en
ta
ti
o
n
T
es
t
C
A
T
O
N
P
G
A
D
H
L
D
C
O
D
C
C
IT
H
2
S
U
R
E
T
D
A
IN
D
V
P
G
E
L
G
L
U
M
A
N
IN
O
S
O
R
R
H
A
S
A
C
M
E
L
A
M
Y
A
R
A
iN
T
S
S
.
T
yp
hi
m
ur
iu
m
D
23
58
0
+
w
–
+
+
+
+
+
–
–
–
+
w
–
+
+
+
+
+
–
–
–
+
S
T
31
3
A
13
0
+
w
–
+
+
+
+
+
–
–
–
+
w
–
+
+
+
+
+
–
+
–
+
N
T
S
S
.
T
yp
hi
m
ur
iu
m
S
L1
34
4
+
–
+
+
+
–
+
–
–
–
–
–
+
+
–
+
+
–
+
–
+
S
.T
yp
hi
T
y2
–
–
+
+
–
–
+
w
–
–
–
–
–
+
+
–
+
–
–
+
–
–
A
bb
re
vi
at
io
ns
:C
A
T
:c
at
al
as
e;
O
N
P
G
:o
rt
ho
-N
itr
op
he
ny
l-β
-g
al
ac
to
si
de
;A
D
H
:a
rg
in
in
e
di
hy
dr
ol
as
e;
LD
C
:l
ys
in
e
de
ca
rb
ox
yl
as
e;
O
D
C
:o
rn
ith
in
in
e
de
ca
rb
ox
yl
as
e;
C
IT
:c
itr
at
e
ut
ili
za
tio
n;
H
2S
:h
yd
og
en
su
lfi
de
pr
od
uc
tio
n;
U
R
E
:u
re
as
e—
U
re
a
hy
dr
ol
ys
is
;T
D
A
:t
ry
pt
op
ha
n
de
am
in
as
e;
IN
D
:i
nd
ol
e
pr
od
uc
tio
n-
tr
yp
to
ph
an
as
e;
V
P
:V
og
es
-P
ro
sk
au
er
—
ac
et
oi
n
pr
od
uc
tio
n;
G
E
L:
ge
la
tin
as
e;
G
LU
:g
lu
co
se
fe
rm
en
ta
tio
n
/o
xi
da
tio
n;
M
A
N
:m
an
ni
to
lf
er
m
en
ta
tio
n
/o
xi
da
tio
n;
IN
O
:i
no
si
to
lf
er
m
en
ta
tio
n
/o
xi
da
tio
n;
S
O
R
:s
or
bi
to
lf
er
m
en
ta
tio
n
/
ox
id
at
io
n;
R
H
A
:r
ha
m
no
se
fe
rm
en
ta
tio
n
/o
xi
da
tio
n;
S
A
C
:s
ac
ch
ar
os
e
fe
rm
en
ta
tio
n
/o
xi
da
tio
n;
M
E
L:
m
el
ib
io
se
fe
rm
en
ta
tio
n
/o
xi
da
tio
n;
A
M
Y
:a
m
yg
da
lin
fe
rm
en
ta
tio
n/
ox
id
at
io
n;
A
R
A
:a
ra
bi
no
se
fe
rm
en
ta
tio
n/
ox
id
at
io
n.
T
he
w
in
di
ca
te
s
w
ea
k
po
si
tiv
e
re
ac
tio
n.
do
i:1
0.
13
71
/jo
ur
na
l.p
nt
d.
00
03
83
9.
t0
02
In Vivo and In Vitro Characterization of D23580
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0003839 June 19, 2015 10 / 17
ability to utilize the sugar strongly correlated with clinical isolates that were associated with a
Salmonella Enteriditis outbreak [40]. The Voges-Proskauer (VP) reaction, which is typically
negative for Salmonella spp., was found to be weakly positive for D23580 and A130. This result
indicates that these strains are capable of fermenting sugars to pyruvate via the butylene glycol
pathway, which produces neutral end products, including acetoin and 2,3-butanediol. This is
in contrast to other Salmonella pathovars, which typically produce acidic end products and as
such, SL1344 and Ty2 tested negative in the VP reaction. Both D23580 and A130 presented
positive reaction for the citrate test, indicating the ability for these strains to utilize citrate as
the sole carbon source, while all other strains tested were negative. These results were con-
firmed utilizing Simmons’ citrate medium. Catalase tests revealed that while SL1344 displayed
a strong positive reaction to hydrogen peroxide, both D23580 and A130 showed an extremely
weak reaction, which was confirmed by performing a heavier bacterial inoculation as well (S3
Fig). This phenotype was similar to what was observed for Typhi strain Ty2, which is a natu-
rally occurring rpoSmutant and thus impaired in its ability to produce catalase and resist kill-
ing by hydrogen peroxide [41,42].
Discussion
Salmonella remains one of the best-characterized microbial pathogens; however we still have
limited knowledge regarding the distinct pathogenesis mechanisms associated with human
infections, including the invasive, MDR ST313 pathovar that has been responsible for an out-
break of iNTS infections in sub-Saharan Africa. Although genomic analysis of multiple ST313
strains, including D23580, initially indicated the possibility that this pathovar may be evolving
more towards a more host-restricted phenotype like that of S. Typhi due to the presence of
multiple gene deletions and inactivations [1], a subsequent study confirmed that D23580 and a
different ST313 strain, Q456, were not host-restricted and caused an invasive disease in chick-
ens [18]. However, no one has yet assessed the potential lethality of any ST313 strain in a non-
human model.
In this study, we demonstrate that D23580 indeed causes a lethal disease in eight-week-old
female BALB/c mice infected via the peroral route, with a median lethal dose of 4.75 x 105
CFU. This LD50 value is over 4 times lower than what was previously reported for the well-
characterized S. Typhimurium ST19 strain SL1344 [32,33]. This finding is especially intriguing,
given that D23580 spread more rapidly than SL1344 into deeper tissues of the mice, including
the spleen and gall bladder; a finding which is in line with previous reports demonstrating that
D23580 spread faster to the spleen than ST19 strains F98, and 4/74 in chickens [18]. In addi-
tion, a study that was recently published while this manuscript was under review reported the
tissue distribution of several ST313 strains in the liver, bone marrow and gall bladder of
C57BL/6 mice and confirmed that the ST313 strains were indeed able to colonize these sys-
temic sites [43]. However, the authors did not observe a statistical difference in colonization of
these tissues between the ST313 isolates tested and SL1344. Differences in a number of experi-
mental parameters could explain these seemingly divergent results, including differences in 1)
the ST313 strain used to test colonization of these tissues—D23580 (this work) versus other
ST313 isolates [43]; 2) mouse strains used—BALB/c (this work) versus C57BL/6 [43]; 3) route
of infection—peroral (this work) versus oral gavage [43]; and 4) bacterial growth conditions.
In this study, we did not observe any statistical difference between D23580 and SL1344 in
the initial colonization of the Peyer’s patches or intestinal walls (devoid of Peyer’s patches),
indicating that the inherent differences between the dissemination of D23580 and SL1344 in
the mouse model of infection is most likely not due to differences in the initial adherence/inva-
sion of the pathogens to the intestinal epithelium. It is likely that the differences observed in
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the systemic colonization of D23580 within the mouse are multifactorial, including a combina-
tion of differences in stress resistance, survival and replication. A recent study by Ramachan-
dran et al [26] found that D23580 survived better than SL1344 in macrophages. This trend was
similar across multiple ST313 and ST19 strains profiled. Moreover, it was also found that mac-
rophages infected with either ST313 strain D65 or ST19 strain I77 led to an induction of more
proinflammatory cytokines and increased apoptosis in macrophages infected with I77 relative
to those infected with D65. These factors may account for the dissemination differences
between D23580 and SL1344.
During the course of infection, Salmonella encounters a variety of potentially lethal stressors
that can alter its pathogenesis, replication and survival. The ability of the pathogen to resist
these environmental insults can have a profound impact on the duration and severity of the
infection. In this study, we profiled the ability of D23580 to survive exposure to low pH and
found that D23580 displayed an enhanced resistance to acid stress relative to SL1344 in vitro.
Salmonella encounters harsh acidic environments in the host, during its transit through the
stomach as well as within the macrophage phagolysosome [35]. There is previous evidence sug-
gesting a correlation between the acid tolerance response in S. Typhimurium and virulence
[34]. As mentioned, no reservoir has yet been identified for the ST313 pathovar, and it has
been suggested that the mode of transmission may be person-to-person rather than via the
food-borne route [5,6]. Certain pathogens like Shigella, which are predominantly transmitted
person-to-person, tend to possess a high resistance to acid killing in order to survive low gastric
pH and other acidic environments in vivo [44–46]. It is possible that the increased acid stress
resistance of D23580 may be one pathogenesis-related factor that could help to facilitate per-
son-to-person transmission. Future investigations into the role of acid resistance in the patho-
genesis of D23580 and other ST313 isolates may provide additional insight in this regard.
D23580 was also found to exhibit a greater swimming motility than all strains profiled in
this study. The importance of motility for the virulence of S. enterica appears to depend on a
variety of factors, including the type of host as well as the local microenvironment during infec-
tion [47–51]. In mouse models of systemic infection with S. Typhimurium, while motility
appears to regulate some aspects of pathogenesis, it does not appear to be important for viru-
lence [47,51,52]. However, in streptomycin-pretreated mice (which serve as a model of colitis)
motility was shown to play a role in colonization and in the induction of colitis [53]. Similarly,
in 1-day old chicks it was demonstrated that motility was important for both the virulence of S.
Typhimurium as well as its persistence in the liver and spleen [54]. In a calf model of enteroco-
litis, flagella were found to be required for maximum fluid secretion and for the influx of poly-
morphonuclear leukocytes during infection [51]. In vitro infection assays have also been used
to profile the impact of motility on the ability for S. Typhimurium to attach and invade into
cells [48,50,51,55–58]. While many of these infection studies using flat 2-D monolayer cultures
have indicated that the motility is important for the colonization of the intestinal epithelium, a
recent study using our 3-D organotypic model of human intestinal epithelium revealed that an
flhDC flagellar mutant was still able to actively invade at much greater levels than in 2-D mono-
layers without the need for centrifugation during the adherence step, although still to a lesser
extent than wild type [59].
Of particular relevance to ST313 strains, it was previously found that the physiological ori-
gin of clinical isolates might also impact motility in that S. Typhi clinical isolates of blood-
borne origin displayed a significantly higher swimming motility than stool-borne strains [60].
In addition, a previous study reported that while flagella-mediated motility was not required
for invasion, it does lead to enhanced invasion although it was not absolutely required for inva-
sion to occur [50]. Thus it is possible that the greater motility observed in this study for
D23580 may be associated with the enhanced tissue distribution in systemic mice organs as
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compared to SL1344. D23580, which is blood-borne in origin, displayed enhanced motility in
our present study relative to other strains profiled. However, in our present study we observed
a sizeable difference in the motility between the blood-borne ST313 clinical isolates, D23580
and A130, in that A130 was much less motile. A recent comparative study of several ST313
strains (S12, Q55, D65, and S11) with ST19 strains (I77, S52, I41, and I89) found that the
ST313 strains were significantly less motile and produced less flagellin than the ST19 strains
[26]. Additional studies are needed to better understand the potential role of this enhanced
response on the infection properties of D23580.
In an effort to identify possible metabolic characteristics of D23580 associated with its
enhanced ability to reach deep tissues in mice following p.o. infection, we performed a series of
biochemical analyses to identify differences between this ST313 strain and classic Salmonella
pathovars. Key differences were observed for D23580 for three biochemical tests, including
melibiose and inositol utilization and the Voges-Proskauer test. In particular, it is intriguing
that both ST313 strains were able to use inositol, since 1) increased inositol levels are found
early in the course of HIV-related brain disease [61] and ST313 infections in adults are strongly
associated with HIV infected individuals [8,62,63], and 2) inositol metabolism is important for
the intraerythrocytic development of the malarial parasite Plasmodium falciparum [64] and
infants with malaria are at high risk for ST313 infections [1,65,66]. In addition to the differ-
ences described above, D23580 was also the only strain unable to use melibiose–a distinct char-
acteristic that has been associated with another clinical outbreak [40], and may be useful for
discriminating isolates during biotyping. Relevant to these findings, Okoro et al. recently
reported single nucleotide polymorphisms and pseudogenes associated with metabolism in
ST313 isolates and experimentally showed using phenotype microarrays that these isolates dif-
fered from ST19 strains (including reference strain ST4/74, which is the parental strain of
SL1344) in their utilization of select carbon sources, including L-tartaric acid, tricarballyic acid
and meso-tartaric acid [43]. In addition, it was observed that ST313 strains more readily used
melibionic acid (a derivative of melibiose), than the ST19 strains tested [43]. Collectively, our
observations may provide clues for future studies into the metabolic adaptation and pathogenic
mechanisms of ST313 strains.
Supporting Information
S1 Fig. Growth curves of D23580 and SL1344. Bacterial cultures were initiated in LB with aer-
ation (180 rpm) overnight for 15 hours at 37°C. The following day, overnight cultures were
inoculated into 5 mL sterile LB at a 1:200 dilution and subsequently grown at 37°C with aera-
tion. Cultures were monitored by plating on LB agar for viable colony-forming units (CFU)
and measuring the corresponding optical density at 600 nm (OD600).
(TIFF)
S2 Fig. Tissue distribution of D23580 and SL1344 in mice following peroral infection.
D23580 or SL1344 cultured to late log phase was administered perorally to 8-week-old female
BALB/c mice at 108 CFU per dose (5 mice total). The bacterial load in Peyer’s patches and
mesenteric lymph nodes on Day 1 following infection (A) as well as within the intestinal con-
tents and the intestinal wall (excluding Peyer’s patches) on Days 1, 3, and 5 (B, C) are shown.
The data are presented as the mean of either the CFU per gram of tissue or per total organ
(mesenteric lymph nodes). The horizontal bar indicates geometric means. The data shown rep-
resent a single experimental trial using five mice. Since no statistical differences were observed
on Day 1 for any tissue or for Days 3 and 5 for the intestinal wall or intestinal contents, these
experiments were not replicated.
(TIFF)
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S3 Fig. ST313 strains display a weakly positive catalase reaction. Bacterial colonies of each
strain (D23580, SL1344, A130 and Ty2) were picked onto sterile polystyrene plastic petri dishes
from plates grown overnight at 37°C. One to two drops of hydrogen peroxide was then added
simultaneously to each strain and immediately imaged for bubble formation.
(JPG)
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